ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $726,000 | -1.4% | 497,000 | -4.1% | 0.00% | 0.0% |
Q4 2016 | $736,000 | -22.8% | 518,400 | -4.8% | 0.00% | -50.0% |
Q3 2016 | $953,000 | -4.2% | 544,800 | -6.4% | 0.00% | 0.0% |
Q2 2016 | $995,000 | -15.8% | 582,100 | -3.0% | 0.00% | 0.0% |
Q1 2016 | $1,182,000 | -2.2% | 600,200 | -5.7% | 0.00% | 0.0% |
Q4 2015 | $1,209,000 | -0.5% | 636,300 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $1,215,000 | -58.8% | 636,300 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $2,952,000 | -2.7% | 636,300 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $3,035,000 | 0.0% | 636,300 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $3,035,000 | +13.8% | 636,300 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $2,666,000 | -28.5% | 636,300 | 0.0% | 0.00% | -20.0% |
Q2 2014 | $3,729,000 | -10.1% | 636,300 | -1.4% | 0.01% | -16.7% |
Q1 2014 | $4,148,000 | +7.5% | 645,200 | 0.0% | 0.01% | 0.0% |
Q4 2013 | $3,858,000 | +11.8% | 645,200 | -1.5% | 0.01% | 0.0% |
Q3 2013 | $3,452,000 | -21.2% | 655,035 | +15.1% | 0.01% | -33.3% |
Q2 2013 | $4,381,000 | – | 568,935 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 1,952,891 | $2,852,000 | 0.72% |
Nine Chapters Capital Management LLC | 180,200 | $263,000 | 0.36% |
Camber Capital Management LP | 4,250,000 | $6,205,000 | 0.25% |
TFS CAPITAL LLC | 340,092 | $497,000 | 0.16% |
ASCEND CAPITAL, LLC | 1,008,949 | $1,473,000 | 0.07% |
Acrospire Investment Management LLC | 39,781 | $58,000 | 0.05% |
OXFORD ASSET MANAGEMENT LLP | 1,081,912 | $1,580,000 | 0.04% |
Jacobi Capital Management LLC | 35,000 | $49,000 | 0.02% |
Renaissance Technologies | 8,479,445 | $12,380,000 | 0.02% |
A.R.T. Advisors, LLC | 238,036 | $347,000 | 0.02% |